Targeting protein interactions of p53 for therapeutic intervention: Success in a frustrated landscape - Commentary

Cell Cycle

Volumn 8, Issue 22, 2009, Pages 3631-3635

  Blundell, Tom L ^a   Bolanos Garcia, Victor M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; PROTEIN MDM2; PROTEIN P53; PROTEIN P63; PROTEIN P73;

AMINO TERMINAL SEQUENCE; APOPTOSIS; BINDING AFFINITY; BINDING SITE; CELL CYCLE ARREST; CRYSTAL STRUCTURE; DNA REPAIR; DRUG TARGETING; ENERGY; ENTHALPY; ENTROPY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR MODEL; NOTE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 70450073088     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.22.10311     Document Type: Note

References (11)

1. Congreve M, et al. Drug Discov Today 2005; 10:895-907
2. Wells J, et al. Nature 2007; 450:1001-1009
3. Momand J, et al. Gene 2000; 242:15-29.
4. Haupt Y, et al. Nature 1997; 387:296-299
5. Hyvonen M, et al. Unpublished results. 2009.
6. Dunker AK, et al. FeBS J 2005; 272:5129-5148
7. Blundell TL, et al. Phil Trans R Soc B 2006; 361:413-423
8. Madhumalar A, et al. Cell Cycle 2009.
9. Lipinski CA, et al. Adv Drug Deliv Rev 2001; 46:3-26.
10. Kussie PH, et al. Science 1996; 274:948-953
11. Pazgiera M, et al. Proc Natl Acad Sci USA 2009; 106:4665-4667